Opko Health Net Worth
Opko Health Net Worth Breakdown | OPK |
Opko Health Net Worth Analysis
Opko Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Opko Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Opko Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Opko Health's net worth analysis. One common approach is to calculate Opko Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Opko Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Opko Health's net worth. This approach calculates the present value of Opko Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Opko Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Opko Health's net worth. This involves comparing Opko Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Opko Health's net worth relative to its peers.
To determine if Opko Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Opko Health's net worth research are outlined below:
| Opko Health generated a negative expected return over the last 90 days | |
| Opko Health may become a speculative penny stock | |
| The company reported the last year's revenue of 713.14 M. Reported Net Loss for the year was (53.22 M) with profit before taxes, overhead, and interest of 104.94 M. | |
| Opko Health has about 210.46 M in cash with (183.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27. | |
| Roughly 47.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: NextPlat Issues Interim CEO Update Shareholder Letter |
Opko Health Quarterly Good Will |
|
Opko Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Opko Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Opko Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Opko Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Opko Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Opko Health backward and forwards among themselves. Opko Health's institutional investor refers to the entity that pools money to purchase Opko Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bank Of America Corp | 2025-03-31 | 4.2 M | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 4.1 M | Goldman Sachs Group Inc | 2025-03-31 | 4 M | Lazard Asset Management Llc | 2025-03-31 | 3.6 M | Northern Trust Corp | 2025-03-31 | 3.5 M | Charles Schwab Investment Management Inc | 2025-03-31 | 2.7 M | Jpmorgan Chase & Co | 2025-03-31 | 2.5 M | Ubs Group Ag | 2025-03-31 | 2.4 M | Dimensional Fund Advisors, Inc. | 2025-03-31 | 2.2 M | Rubric Capital Management Lp | 2025-03-31 | 48.7 M | Vanguard Group Inc | 2025-03-31 | 29.5 M |
Follow Opko Health's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 1.06 B.Project Opko Health's profitablity
The company has Net Profit Margin of (0.06) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.45) %, which entails that for every $100 of revenue, it lost $0.45.When accessing Opko Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Opko Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Opko Health's profitability and make more informed investment decisions.
Evaluate Opko Health's management efficiency
Opko Health has Return on Asset of (0.082) % which means that on every $100 spent on assets, it lost $0.082. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0304) %, meaning that it generated no profit with money invested by stockholders. Opko Health's management efficiency ratios could be used to measure how well Opko Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Opko Health's Liabilities And Stockholders Equity is quite stable compared to the past year. Non Current Liabilities Total is expected to rise to about 673.8 M this year, although the value of Total Current Liabilities will most likely fall to about 107.5 M.Effective leadership at Opko Health drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Enterprise Value Revenue 1.6297 | Revenue | Quarterly Revenue Growth (0.14) | Revenue Per Share 1.006 | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Opko Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Opko Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Opko Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Opko Health time-series forecasting models is one of many Opko Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Opko Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Opko Health Earnings per Share Projection vs Actual
Opko Health Corporate Executives
Elected by the shareholders, the Opko Health's board of directors comprises two types of representatives: Opko Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Opko. The board's role is to monitor Opko Health's management team and ensure that shareholders' interests are well served. Opko Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Opko Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Adam Logal | CFO, Chief Accounting Officer, Sr. VP and Treasurer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.191 | Earnings Share (0.06) | Revenue Per Share 1.006 | Quarterly Revenue Growth (0.14) | Return On Assets (0.08) |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.